Xoma | XOMA - Equity Capital And Reserves

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $87.94M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Agenus USD -274.14M 80.46M Sep/2025
Agios Pharmaceuticals USD 1.19B 91.22M Dec/2025
Ardelyx USD 154.28M 14.75M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Celldex Therapeutics USD 598.36M 57.04M Sep/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Emergent BioSolutions USD 649.3M 47.9M Dec/2023
Incyte USD 5.17B 516.28M Dec/2025
MacroGenics USD 67M 20.38M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novartis USD 44.33B 2.28B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Prothena USD 294.99M 29.34M Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Xoma USD 87.94M 15.5M Sep/2025